Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Welcome to the Breast Cancer Sessions with the Video Journal of Oncology (VJOncology).
Watch our expert roundtable discussions to learn about the latest advances in breast cancer research from the 2025 American Society of Clinical Oncology (ASCO) Meeting and what the data means for clinical practice.
Welcome to The Breast Cancer Sessions brought to you by the Video Journal of Oncology (VJOncology).
Leading breast cancer experts Kevin Kalinsky and Komal Jhaveri review the latest updates in breast cancer from the 2025 American Society of Clinical Oncology (ASCO) Meeting!
Topics covered include updates on pivotal, practice-changing trials such as the DESTINY-Breast09 trial (NCT04784715) of first-line trastuzumab deruxtecan (T-DXd) and pertuzumab in patients with HER2+ breast cancer, and the ASCENT-04 trial (NCT05382286) of sacituzumab govitecan and pembrolizumab in PD-L1-positive triple-negative breast cancer (TNBC).
